<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pramoxine and hydrocortisone: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pramoxine and hydrocortisone: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Pramoxine and hydrocortisone: Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="11836" href="/d/html/11836.html" rel="external">see "Pramoxine and hydrocortisone: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F212420"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Analpram Advanced Kit [DSC];</li>
<li>Analpram E [DSC];</li>
<li>Analpram HC;</li>
<li>Epifoam;</li>
<li>Novacort [DSC];</li>
<li>PramCort;</li>
<li>Pramosone;</li>
<li>Pramosone E [DSC];</li>
<li>ProCort;</li>
<li>ProctoFoam HC</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52914138"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Pramox HC;</li>
<li>Proctofoam-HC</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F212433"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Anesthetic/Corticosteroid</li></ul></div>
<div class="block doa drugH1Div" id="F212424"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="39c75f78-9f15-44b6-922f-ec39037b6cf8">Anorectal inflammation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Anorectal inflammation (rectal suppository): Rectal: </b>Insert 1 suppository 2 times daily; in severe cases, may increase to 1 suppository 3 times daily or 2 suppositories 2 times daily. Treat nonspecific proctitis for 2 weeks and factitial proctitis for 6 to 8 weeks or less according to clinical response.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="db00c349-e8c7-4629-a65f-c9656671bb40">Dermatoses</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Dermatoses:</b>
<b>Topical, rectal:</b> Apply to affected areas 3 to 4 times daily.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50990731"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;margin-left:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block doha drugH1Div" id="F50988098"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;margin-left:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block doe drugH1Div" id="F212425"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F45131535"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="db00c349-e8c7-4629-a65f-c9656671bb40">Dermatoses</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Dermatoses:</b> Infants, Children, and Adolescents: Topical, rectal: Refer to adult dosing.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51154224"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block dohp drugH1Div" id="F51154225"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block adr drugH1Div" id="F212402"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">See individual agents.</p></div>
<div class="block coi drugH1Div" id="F212414"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to pramoxine, hydrocortisone, or any component of the formulation</p></div>
<div class="block war drugH1Div" id="F212399"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Adrenal suppression: May cause hypercortisolism or suppression of the hypothalamic-pituitary-adrenal (HPA) axis, particularly in younger children or in patients receiving high doses for prolonged periods. HPA axis suppression may lead to adrenal crisis.</p>
<p style="text-indent:-2em;margin-left:4em;">• Contact dermatitis: May occur; discontinue use if irritation occurs and treat appropriately.</p>
<p style="text-indent:-2em;margin-left:4em;">• Immunosuppression: Prolonged use of corticosteroids may result in fungal or bacterial superinfection; discontinue if dermatological infection persists despite appropriate antimicrobial therapy.</p>
<p style="text-indent:-2em;margin-left:4em;">• Systemic effects: Topical corticosteroids may be absorbed percutaneously. Absorption of topical corticosteroids may cause manifestations of Cushing's syndrome, hyperglycemia, or glycosuria. Absorption is increased by the use of occlusive dressings, application to denuded skin, prolonged use, or application to large surface areas.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Special populations:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Older adult: Because of the risk of adverse effects associated with systemic absorption, topical corticosteroids should be used cautiously in the elderly in the smallest possible effective dose for the shortest duration.</p>
<p style="text-indent:-2em;margin-left:4em;">• Pediatric: Children may absorb proportionally larger amounts after topical application and may be more prone to systemic effects. HPA axis suppression, intracranial hypertension, and Cushing syndrome have been reported in children receiving topical corticosteroids. Prolonged use may affect growth velocity; growth should be routinely monitored in pediatric patients.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: Avoid use of topical preparations with occlusive dressings or on weeping or exudative lesions.</p>
<p style="text-indent:-2em;margin-left:4em;">• Rectal foam: Do not insert any part of the aerosol container directly into the anus. Discontinue use if there is no evidence of clinical or proctologic improvement within 2 or 3 weeks after initiation of therapy or if the condition worsens.</p>
<p style="text-indent:-2em;margin-left:4em;">• Rectal suppositories: Perform a proper proctologic exam prior to beginning therapy.</p></div>
<div class="block foc drugH1Div" id="F212408"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product</p>
<p style="text-indent:0em;">Aerosol, foam, rectal:</p>
<p style="text-indent:-2em;margin-left:4em;">ProctoFoam HC: Pramoxine hydrochloride 1% and hydrocortisone acetate 1% (10 g)</p>
<p style="text-indent:0em;">Aerosol, foam, topical:</p>
<p style="text-indent:-2em;margin-left:4em;">Epifoam: Pramoxine hydrochloride 1% and hydrocortisone acetate 1% (10 g)</p>
<p style="text-indent:-2em;margin-left:2em;">Cream, topical:</p>
<p style="text-indent:-2em;margin-left:4em;">Analpram Advanced Kit: Pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% [kit includes Analpram HC cream, diosmiplex (Vasculera) tablets, AloeClean wipes, and applicators] [DSC]</p>
<p style="text-indent:-2em;margin-left:4em;">Analpram E Kit: Pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% (4 g [DSC], 30 g [DSC]) [kit includes Prax wipes]</p>
<p style="text-indent:-2em;margin-left:4em;">Analpram HC: Pramoxine hydrochloride 1% and hydrocortisone acetate 1% (4 g, 30 g); pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% (4 g, 30 g)</p>
<p style="text-indent:-2em;margin-left:4em;">PramCort: Pramoxine hydrochloride 1% and hydrocortisone acetate 1% (30 g) [contains propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;">Pramosone: Pramoxine hydrochloride 1% and hydrocortisone acetate 1% (30 g, 60 g); pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% (30 g, 60 g)</p>
<p style="text-indent:-2em;margin-left:4em;">Pramosone E: Pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% (30 g [DSC], 60 g [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;">ProCort: Pramoxine hydrochloride 1.15% and hydrocortisone acetate 1.85% (60 g)</p>
<p style="text-indent:-2em;margin-left:4em;">Generic: Pramoxine hydrochloride 1% and hydrocortisone acetate 1% (30 g); Pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% (30 g)</p>
<p style="text-indent:-2em;margin-left:2em;">Gel, topical:</p>
<p style="text-indent:-2em;margin-left:4em;">Novacort: Pramoxine hydrochloride 1% and hydrocortisone acetate 2% (29 g [DSC]) [contains aloe, benzyl alcohol, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:2em;">Lotion, topical:</p>
<p style="text-indent:-2em;margin-left:4em;">Analpram-HC: Pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% (60 mL)</p>
<p style="text-indent:-2em;margin-left:4em;">Pramosone: Pramoxine hydrochloride 1% and hydrocortisone acetate 1% (60 mL, 120 mL, 240 mL); pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% (60 mL, 120 mL)</p>
<p style="text-indent:-2em;margin-left:2em;">Ointment, topical:</p>
<p style="text-indent:-2em;margin-left:4em;">Pramosone: Pramoxine hydrochloride 1% and hydrocortisone acetate 1% (30 g); pramoxine hydrochloride 1% and hydrocortisone acetate 2.5% (30 g)</p>
<p style="text-indent:-2em;margin-left:2em;">Suppository, Rectal:</p>
<p style="text-indent:-2em;margin-left:4em;">Generic: Pramoxine hydrochloride 18 mg and hydrocortisone acetate 25 mg</p></div>
<div class="block geq drugH1Div" id="F212396"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes: Cream</p></div>
<div class="block fee drugH1Div" id="F212415"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Analpram HC External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.5-1% (per gram): $10.26</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Analpram HC Singles External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.5-1% (per gram): $5.06</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Analpram-HC External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1-1% (per gram): $10.88</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Hydrocort-Pramoxine (Perianal) External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.5-1% (per gram): $2.26 - $4.57</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Hydrocortisone Ace-Pramoxine External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1-1% (per gram): $4.85</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Pramosone External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1-1% (per gram): $10.29</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1-2.5% (per gram): $11.21</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (ProCort External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1.85-1.15% (per gram): $7.60</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Foam</b> (Epifoam External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1-1% (per gram): $10.90</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Foam</b> (Proctofoam HC External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1-1% (per gram): $21.16</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Lotion</b> (Analpram-HC External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.5-1% (per mL): $6.54</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Lotion</b> (Pramosone External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1-1% (per mL): $5.01</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1-2.5% (per mL): $6.29</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Ointment</b> (Pramosone External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1-1% (per gram): $9.79</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1-2.5% (per gram): $10.20</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Suppository</b> (Hydrocortisone Ace-Pramoxine Rectal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">25-18 mg (per each): $41.40</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F212411"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Topical:</b> Apply a thin film to the affected area. The treated area should not be bandaged or otherwise covered or wrapped as to be occlusive; however, occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. Discontinue the use of occlusive dressings if infection develops. The use of tight-fitting diapers or plastic pants should be avoided.</p>
<p style="text-indent:-2em;margin-left:4em;">Foam: Epifoam: Shake vigorously for 5 to 10 seconds before each use. May apply directly to the affected are or alternatively, may dispense a small amount to a pad and apply to affected areas. Do not insert container into vagina or anus. Disassemble container and cap after each use and rinse with warm water.</p>
<p style="text-indent:-2em;margin-left:4em;">Lotion: Shake well before use.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Rectal:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Proctofoam HC: Shake vigorously for 5 to 10 seconds prior to use. Do not remove cap during use. Hold container upright to fill applicator. Gently insert applicator tip into anus. Only use applicator provided by manufacturer; do not insert any part of the aerosol container in the anus. Clean applicator after each use with warm water. For perianal application, transfer a small amount on to a tissue and gently rub into affected area.</p>
<p style="text-indent:-2em;margin-left:4em;">Suppository: Holding suppository upright, carefully remove from wrapper, exposing pointed end first. Insert pointed end of suppository into the rectum in the morning and at night. Avoid handling unwrapped suppository for too long.</p></div>
<div class="block admp drugH1Div" id="F52613644"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:-2em;margin-left:2em;">Topical: For external use only; avoid contact with eyes. Do not bandage or use occlusive dressing unless treating psoriasis or recalcitrant conditions. Discontinue the use of occlusive dressings if infection develops. The use of tight-fitting diapers or plastic pants should be avoided in pediatric patients being treated in the diaper area.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Cream, Ointment:</i> Apply a thin film to the affected area.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Foam</i>: Epifoam: Shake vigorously for 5 to 10 seconds before each use. Prime prior to use by holding upright and pressing down on applicator several times until foam appears. May apply directly to the affected area or alternatively, may dispense a small amount to a pad and apply to affected areas. Do not insert container into vagina or anus. Disassemble container and cap after each use and rinse with warm water.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Lotion:</i> Shake well before use. Apply thin film to affected area.</p>
<p style="text-indent:-2em;margin-left:2em;">Rectal: Proctofoam HC: Place cap on top of container; shake vigorously for 5 to 10 seconds prior to each use. Do not remove cap during use. Hold container upright to fill applicator. Place tip of applicator on top of container cap, pull plunger past fill line on applicator barrel. Prime container by pressing down and releasing; with initial prime a burst of air comes out; usually takes 1 to 2 pumps for foam to appear. Fill applicator barrel by pressing down for 1 to 2 seconds, release, and wait to allow foam to appear in applicator barrel (5 to 10 seconds); repeat until foam reaches fill line; usually takes 3 to 4 pumps to reach fill line. Foam should not go beyond fill line or it will create back up. Gently insert applicator tip into anus, do not insert past the anus. Only use applicator provided by manufacturer; do not insert any part of the aerosol container in the anus. Clean applicator after each use with warm water. For perianal application, transfer a small amount to a tissue and gently rub into affected area.</p></div>
<div class="block use drugH1Div" id="F212410"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Anorectal inflammation (rectal suppository):</b> Temporary relief of inflammation associated with hemorrhoids, post irradiation (factitial) proctitis, and other inflammatory conditions of the anorectum and pruritus ani; adjunct in the treatment of chronic ulcerative colitis; cryptitis.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dermatoses:</b> Relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.</p></div>
<div class="block mst drugH1Div" id="F212440"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Pramosone may be confused with predniSONE</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">Pediatric patients: High-risk medication:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">KIDs List: Medium, high, and very high potency topical corticosteroids, when used in neonates and infants &lt;1 year of age for diaper dermatitis, are identified on the Key Potentially Inappropriate Drugs in Pediatrics (KIDs) list; use should be avoided due to risk of adrenal suppression; systemic absorption is higher in pediatric patients than adults (strong recommendation; low quality of evidence) (PPA [Meyers 2020]).</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F212430"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">Refer to individual components.</p></div>
<div class="block dri drugH1Div" id="F212403"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Calcipotriene: Hydrocortisone (Topical) may diminish the therapeutic effect of Calcipotriene.  Management: Monitor for reduced calcipotriene efficacy if combined with hydrocortisone valerate. Consider separating the administration of these agents by 10 to 12 hours to minimize the risk of this potential interaction.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Methemoglobinemia Associated Agents: May enhance the adverse/toxic effect of Local Anesthetics. Specifically, the risk for methemoglobinemia may be increased.<i> Risk C: Monitor therapy</i></p></div>
<div class="block pri drugH1Div" id="F212416"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Adverse events have been observed with corticosteroids in animal reproduction studies. Rectal use of pramoxine and hydrocortisone for the treatment of hemorrhoids in the third trimester of pregnancy was not shown to affect birth weight (Ebrahimi 2011). Also refer to Hydrocortisone (Topical)  monograph.</p></div>
<div class="block brc drugH1Div" id="F13383353"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:0em;display:inline">Refer to Hydrocortisone (Topical)  monograph.</p></div>
<div class="block mop drugH1Div" id="F45131538"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;">May consider the use of urinary free cortisol test and ACTH stimulation test in patients with suspected hypothalamic-pituitary-adrenal (HPA) axis suppression.</p></div>
<div class="block pha drugH1Div" id="F13383354"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">See individual agents. </p></div>
<div class="block phk drugH1Div" id="F212413"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:0em;display:inline">See individual agents.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F212417"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Proctofoam</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Anusol duo | Tocorectal</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Proctofoam HC</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Proctofoam HC</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Pramacort</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Proctocream hc | Proctofoam HC</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Proctofoam HC</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Epifoam | Proctofoam HC</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Proctofoam HC</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Proctofoam HC</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Analpram E | Analpram hydrocortisone | Endaroid | Epifoam | Hydrocortisone Acetate Pramoxin HCl | Hydrocortisone acetate pramoxine hcl | Hydrocortisone/Pramoxine | Pramcort | Pramosone | Pramosone E | Procort | Proctocream hc | Proctofoam HC | Z Pram | Zone-a | Zone-a forte | Zypram</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Prakortil</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Hydroxine | Prasone</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference">
                  Analpram E cream (hydrocortisone/pramoxine) [prescribing information]. Roswell, Georgia: Sebela Pharmaceuticals; January 2015.</div>
</li>
<li>
<div class="reference">
                  Analpram HC cream (hydrocortisone/pramoxine) [prescribing information]. Roswell, Georgia: Sebela Pharmaceuticals; April 2017.</div>
</li>
<li>
<div class="reference">
                  Analpram HC lotion (hydrocortisone/pramoxine) [prescribing information]. Roswell, Georgia: Sebela Pharmaceuticals; February 2015.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21352635">
<a name="21352635"></a>Ebrahimi N, Vohra S, Gedeon C, et al, "The Fetal Safety of Hydrocortisone-Pramoxine (Proctofoam-HC) for the Treatment of Hemorrhoids in Late Pregnancy," <i>J Obstet Gynaecol Can</i>, 2011, 33(2):153-8.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/pramoxine-and-hydrocortisone-drug-information/abstract-text/21352635/pubmed" id="21352635" target="_blank">21352635</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Epifoam (hydrocortisone/pramoxine) [prescribing information]. Somerset, NJ: Meda Pharmaceuticals Inc; received May 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12441327">
<a name="12441327"></a>Goedert JJ, Vitale F, Lauria C, et al, “Risk Factors for Classical Kaposi's Sarcoma,” <i>J Natl Cancer Inst</i>, 2002, 94(22):1712-8.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/pramoxine-and-hydrocortisone-drug-information/abstract-text/12441327/pubmed" id="12441327" target="_blank">12441327</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Hydrocortisone and pramoxine suppositories [prescribing information]. Maryland Heights, MO: Pageview Pharmaceuticals; January 2022.</div>
</li>
<li>
<div class="reference">
                  Novacort (hydrocortisone/pramoxine) [prescribing information]. Chicago, IL: Novum Pharma, LLC; November 2018.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32265601">
<a name="32265601"></a>Meyers RS, Thackray J, Matson KL, et al. <i>K</i>ey Potentially <i>I</i>nappropriate <i>D</i>rugs in Pediatrics: The KIDs List. <i>J Pediatr Pharmacol Ther</i>. 2020;25(3):175-191.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/pramoxine-and-hydrocortisone-drug-information/abstract-text/32265601/pubmed" id="32265601" target="_blank">32265601</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Pramcort cream (hydrocortisone/pramoxine) [prescribing information]. Rochester, NY: Rochester Pharmaceuticals; June 2013.</div>
</li>
<li>
<div class="reference">
                  Pramosone cream 1%/1% (hydrocortisone/pramoxine) [prescribing information]. Roswell, Georgia: Sebela Pharmaceuticals; October 2014.</div>
</li>
<li>
<div class="reference">
                  Pramosone cream 2.5%/2.5% (hydrocortisone/pramoxine) [prescribing information]. Roswell, Georgia: Sebela Pharmaceuticals; 2014.</div>
</li>
<li>
<div class="reference">
                  Pramosone E cream 2.5%/2.5% (hydrocortisone/pramoxine) [prescribing information]. Roswell, Georgia: Sebela Pharmaceuticals; 2014.</div>
</li>
<li>
<div class="reference">
                  Pramosone Lotion 1%/2.5% (hydrocortisone/pramoxine) [prescribing information]. Roswell, Georgia: Sebela Pharmaceuticals; April 2015.</div>
</li>
<li>
<div class="reference">
                  Pramosone Ointment (hydrocortisone/pramoxine) [prescribing information]. Roswell, Georgia: Sebela Pharmaceuticals; February 2015.</div>
</li>
<li>
<div class="reference">
                  Procort cream (hydrocortisone acetate and pramoxine hydrochloride) [prescribing information]. Berwyn, PA: Women's Choice Pharmaceuticals; May 2018.</div>
</li>
<li>
<div class="reference">
                  Proctofoam (hydrocortisone/pramoxine) [prescribing information]. Somerset, NJ: Meda Pharmaceuticals; April 2020.</div>
</li></ol></div><div id="topicVersionRevision">Topic 10068 Version 199.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
